Literature DB >> 17521338

Bone morphogenetic protein signaling in stem cells--one signal, many consequences.

Toni U Wagner1.   

Abstract

Bone morphogenetic protein (BMP) signals play key roles throughout embryology, from the earliest patterning events, via tissue specification, through organ development and again in germ cell differentiation. While both input and the transducer molecules are rather well studied, the final outcome of a BMP signal is basically unpredictable and differs enormously between previously studied cell types. As already suggested by their name, BMPs exhibit most of their (known) functions on stem cells and precursor cells, usually driving them into various types of differentiation or death. In this minireview, some prime examples of BMP effects on several very different stem-cell types are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17521338     DOI: 10.1111/j.1742-4658.2007.05839.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  13 in total

1.  Bone morphogenetic protein-2 and -6 heterodimer illustrates the nature of ligand-receptor assembly.

Authors:  Michael J Isaacs; Yasuhiko Kawakami; George P Allendorph; Byung-Hak Yoon; Juan Carlos Izpisua Belmonte; Senyon Choe
Journal:  Mol Endocrinol       Date:  2010-05-19

Review 2.  The reciprocal relationship between primordial germ cells and pluripotent stem cells.

Authors:  Mehdi Pirouz; Alexander Klimke; Michael Kessel
Journal:  J Mol Med (Berl)       Date:  2012-05-15       Impact factor: 4.599

3.  Transcriptional profiling by RNA-Seq of peri-attachment porcine embryos generated by a variety of assisted reproductive technologies.

Authors:  S Clay Isom; John R Stevens; Rongfeng Li; William G Spollen; Lindsay Cox; Lee D Spate; Clifton N Murphy; Randall S Prather
Journal:  Physiol Genomics       Date:  2013-05-21       Impact factor: 3.107

Review 4.  Cord blood--an alternative source for bone regeneration.

Authors:  Marcus Jäger; Christoph Zilkens; Bernd Bittersohl; Rüdiger Krauspe
Journal:  Stem Cell Rev Rep       Date:  2009-08-04       Impact factor: 5.739

5.  Sustained release of bone morphogenetic protein-4 in adult rabbit extraocular muscle results in decreased force and muscle size: potential for strabismus treatment.

Authors:  Brian C Anderson; Mark L Daniel; Jeffrey D Kendall; Stephen P Christiansen; Linda K McLoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-08       Impact factor: 4.799

Review 6.  Fibrodysplasia ossificans progressiva: clinical course, genetic mutations and genotype-phenotype correlation.

Authors:  Irina Hüning; Gabriele Gillessen-Kaesbach
Journal:  Mol Syndromol       Date:  2014-08-07

7.  BMP-2/6 heterodimer is more effective than BMP-2 or BMP-6 homodimers as inductor of differentiation of human embryonic stem cells.

Authors:  Elvira Valera; Michael J Isaacs; Yasuhiko Kawakami; Juan Carlos Izpisúa Belmonte; Senyon Choe
Journal:  PLoS One       Date:  2010-06-17       Impact factor: 3.240

8.  Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1.

Authors:  Frederick S Kaplan; Meiqi Xu; Petra Seemann; J Michael Connor; David L Glaser; Liam Carroll; Patricia Delai; Elisabeth Fastnacht-Urban; Stephen J Forman; Gabriele Gillessen-Kaesbach; Julie Hoover-Fong; Bernhard Köster; Richard M Pauli; William Reardon; Syed-Adeel Zaidi; Michael Zasloff; Rolf Morhart; Stefan Mundlos; Jay Groppe; Eileen M Shore
Journal:  Hum Mutat       Date:  2009-03       Impact factor: 4.878

9.  Neogenin interacts with hemojuvelin through its two membrane-proximal fibronectin type III domains.

Authors:  Fan Yang; Anthony P West; George P Allendorph; Senyon Choe; Pamela J Bjorkman
Journal:  Biochemistry       Date:  2008-03-13       Impact factor: 3.162

Review 10.  The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling.

Authors:  Frederick S Kaplan; Robert J Pignolo; Eileen M Shore
Journal:  Cytokine Growth Factor Rev       Date:  2009-11-06       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.